Abstract
Point-of-care testing (POCT) known as near-patient testing has a relatively lower cost and short turnaround time. In this study, we performed the evaluation of the Cues COVID-19 test to detect SARS-CoV-2 in the upper respiratory tract. Given the persistence of the SARS-CoV-2 testing backlog, low availability of testing supply and shortage of licensed personnel in clinical laboratories, we need to migrate more testing capacity to the outpatient setting and the Cue's COVID-19 test is a good option This article is protected by copyright. All rights reserved.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.